Chiome Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19%.

Top 16 shareholders own 14.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.33%	SBI Holdings Inc., Asset Management Arm	1,428,550	JP¥304.3m	0%	0.13%
2.02%	Rakuten Investment Management, Inc.	1,234,000	JP¥262.8m	0%	0.14%
1.63%	Kenji Watanabe	1,000,000	JP¥213.0m	0%	no data
1.63%	Ueda Yagi Tanshi Co. Ltd., Asset Management Arm	998,800	JP¥212.7m	0%	0.4%
1.57%	Kunihiro Ohta	962,700	JP¥205.1m	0%	no data
1.04%	Growth Capital, Inc.	639,400	JP¥136.2m	0%	no data
0.98%	Koji Yoshimura	600,000	JP¥127.8m	0%	no data
0.82%	Matsui Securities Co. Ltd., Asset Management Arm	501,000	JP¥106.7m	0%	0.55%
0.81%	Tetsuo Iisaku	497,000	JP¥105.9m	0%	no data
0.74%	Shigekazu Hirata	455,000	JP¥96.9m	0%	no data
0.65%	Fukutaro Yamato	400,000	JP¥85.2m	0%	no data
0.4%	Shigeru Kobayashi	246,200	JP¥52.4m	0%	no data
0.071%	Arihiko Bijohira	43,500	JP¥9.3m	0%	no data
0.038%	Teruyo Taoka	23,000	JP¥4.9m	0%	no data
0.021%	Akiyuki Furuya	13,000	JP¥2.8m	0%	no data
0.021%	Masamichi Koike	13,000	JP¥2.8m	0%	no data